scholarly journals Use of MAC-ELISA for evaluation of yellow fever vaccination

1992 ◽  
Vol 34 (5) ◽  
pp. 447-450 ◽  
Author(s):  
Rita M. Ribeiro Nogueira ◽  
Hermann G. Schatzmayr ◽  
Marize P. Miagostovich ◽  
Silvia M. B. Cavalcanti ◽  
Ricardo de Carvalho
Keyword(s):  
Immune Response ◽  
Yellow Fever ◽  
Vaccination Programs ◽  
Igm Antibody ◽  
Human Sera ◽  
Yellow Fever Vaccination

An evaluation of the IgM antibody immune response against yellow fever using strain 17D was carried out by MAC-ELISA and PRNT. The results showed an agreement of 97% between both tests and the authors conclude that MAC-ELISA can be used as a specific and sensitive asssay to replace the PRNT for detecting yellow fever antibodies in human sera, after vaccination programs.

scholarly journals Antiviral Immune Response After Live Yellow Fever Vaccination of a Kidney Transplant Recipient Treated With IVIG

2013 ◽  
Vol 95 (9) ◽  
pp. e59-e61 ◽  
Author(s):  
Mark K. Slifka ◽  
Erika Hammarlund ◽  
Matthew W. Lewis ◽  
Elizabeth A. Poore ◽  
Jon M. Hanifin ◽  
...  
Keyword(s):  
Immune Response ◽  
Transplant Recipient ◽  
Kidney Transplant ◽  
Yellow Fever ◽  
Kidney Transplant Recipient ◽  
Antiviral Immune Response ◽  
Yellow Fever Vaccination

scholarly journals Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Katy A M Gaythorpe ◽  
Kaja Abbas ◽  
John Huber ◽  
Andromachi Karachaliou ◽  
Niket Thakkar ◽  
...  
Keyword(s):  
Yellow Fever ◽  
Health Impact ◽  
Vaccination Programs ◽  
Preventive Vaccination ◽  
Catch Up ◽  
Yellow Fever Vaccination ◽  
Gates Foundation ◽  
Measles Outbreaks ◽  
Vaccination Campaigns ◽  
The Impact

Background: Childhood immunisation services have been disrupted by COVID-19. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic. Methods: We used 2-3 models per infection to estimate the health impact of 50% reduced routine vaccination coverage and delaying campaign vaccination for measles, meningococcal A and yellow fever vaccination in 3-6 high burden countries per infection. Results: Reduced routine coverage in 2020 without catch-up vaccination may increase measles and yellow fever disease burden in the modelled countries. Delaying planned campaigns may lead to measles outbreaks and increases in yellow fever burden in some countries. For meningococcal A vaccination, short term disruptions in 2020 are unlikely to have a significant impact. Conclusion: The impact of COVID-19-related disruption to vaccination programs varies between infections and countries. Funding: Bill and Melinda Gates Foundation and Gavi, the Vaccine Alliance.

scholarly journals Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in Europe

2008 ◽  
Vol 197 (11) ◽  
pp. 1577-1584 ◽  
Author(s):  
Hi‐Gung Bae ◽  
Cristina Domingo ◽  
Antonio Tenorio ◽  
Fernando de Ory ◽  
José Muñoz ◽  
...  
Keyword(s):  
Immune Response ◽  
Adverse Events ◽  
Yellow Fever ◽  
Yellow Fever Vaccination

scholarly journals Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries

2021 ◽  
Author(s):  
Katy Gaythorpe ◽  
Kaja Abbas ◽  
John Huber ◽  
Andromachi Karachaliou ◽  
Niket Thakkar ◽  
...  
Keyword(s):  
Yellow Fever ◽  
Health Impact ◽  
Vaccination Programs ◽  
Preventive Vaccination ◽  
Catch Up ◽  
Yellow Fever Vaccination ◽  
Gates Foundation ◽  
Measles Outbreaks ◽  
Vaccination Campaigns ◽  
The Impact

AbstractBackgroundChildhood immunisation services have been disrupted by COVID-19. WHO recommends considering outbreak risk using epidemiological criteria when deciding whether to conduct preventive vaccination campaigns during the pandemic.MethodsWe used 2-3 models per infection to estimate the health impact of 50% reduced routine vaccination coverage and delaying campaign vaccination for measles, meningococcal A and yellow fever vaccination in 3-6 high burden countries per infection.ResultsReduced routine coverage in 2020 without catch-up vaccination may increase measles and yellow fever disease burden in the modelled countries. Delaying planned campaigns may lead to measles outbreaks and increases in yellow fever burden in some countries. For meningococcal A vaccination, short term disruptions in 2020 are unlikely to have a significant impact.ConclusionThe impact of COVID-19-related disruption to vaccination programs varies between infections and countries.FundingBill & Melinda Gates Foundation and Gavi, the Vaccine AllianceImpact statementRoutine and campaign vaccination disruption in 2020 may lead to measles outbreaks and yellow fever burden increases in some countries, but is unlikely to greatly increase meningococcal A burden.

Sign in / Sign up

Export Citation Format

Share Document